Has Rahkil Maizel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $891 in general payments to Rahkil Maizel, MD across 30 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rahkil Maizel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rahkil Maizel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rahkil Maizel, MD

Family Medicine · Oakdale, NYNPI 1356532758

Payments from drug & device makers

$891in general payments, 2019–2025

Across 30 payments — averaging $29.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Welch Allyn$356
Lilly USA, LLC$114
Boehringer Ingelheim$75
Amarin Pharma, Inc.$69
Merck$54
Novo Nordisk$48
plus $175 from 6 others

What the payments were for

Food & beverage$53560%
Gifts$35640%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Welch Allyn	1	$356
Lilly USA, LLC	6	$114
Boehringer Ingelheim	4	$75
Amarin Pharma, Inc.	4	$69
Merck	3	$54
Novo Nordisk	2	$48
Amgen	2	$47
AstraZeneca	2	$31
Johnson & Johnson	2	$31
Philips North America LLC	2	$29
Takeda Pharmaceuticals U.S.A., Inc.	1	$23
Kowa Pharmaceuticals America, Inc.	1	$15

How this compares

$891 in reported general payments places this provider in the 65th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York →

Medicare billing

Part B allowed, 2024

$67,620

Medicare patients

112

Services billed

867

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Levothyroxine Sodium	123	$1,405
Metoprolol Succinate	52	$1,006
Atorvastatin Calcium	99	$631
Rosuvastatin Calcium	48	$560
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide	11	$495
Albuterol Sulfate HfaAlbuterol Sulfate	24	$487
Gabapentin	16	$336
Azelastine Hcl	11	$296
Allopurinol	23	$261
Losartan Potassium	34	$249
Escitalopram Oxalate	31	$246
Pantoprazole Sodium	15	$230
Fluticasone Propionate	36	$229
Pravastatin Sodium	14	$222
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	17	$211

Paid to pharmacies, not to this prescriber.

Other family medicine in Oakdale

Matthew DavisRochester$76.6M
Frank EderBinghamton$46.2M
Suchet PatelEndwell$23.3M
James WildGowanda$2.2M
Michael FedericoEndwell$1.4M
Donald BrautigamWestfield$1.3M
Kimberly DesantisEndwell$1.1M
Michael TugetmanHartsdale$1M
Richard RuhOrchard Park$769K
Eric LorraineEndwell$740K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →